Open access
Oct 2026
Novel Acridone-Based EGFR Inhibitors: Design, Synthesis, and Integrated In Silico-In Vitro Evaluation.
Novel acridone-N-aceto/benzohydrazide derivatives with anti-EGFR activity predicted oral bioavailability and low toxicity, supported by kinetic solubility and plasma stability assays, highlighting their potential as selective p-EGFR Tyr1068 inhibitors for further development.
Nilam Bhusare, Maushmi S. Kumar
· Archiv der Pharmazie · 0 citations